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Abstract
A 71 years old Italian man had type 3 gastric cancer of the greater curvature. Total gastrectomy with splenectomy
and D2 lymph node dissection were performed. After discharge chemotherapy ELF regimen was administred for
6 months. After 16 months from the operation a local recurrence was discovered by CT scan. Surgical en-bloc
resection was performed removing pancreatic tail, splenic colic flexure and a portion of left diaphragm. Histological
examination confirmed local recurrence of gastric adenocarcinoma infiltrating pancreas, colon and diaphragm with
lymph node metastasis.
Introduction
In Western countries gastric cancer still represents a dis-
abling disease: unfortunately late diagnosis is common and
loco-regional recurrence rate after surgery alone is high
especially in patients with advanced stage disease at the
time of diagnosis (gastric wall penetration and lymph node
metastasis). Local recurrence may occur also in those
patient which had R0 resection: management of these
cases is extremely difficult for the involvement of regional
structures resulting in poor surgical chances. Therefore
multidisciplinary therapeutic approach is necessary to
achieve better results. The aim of this report is to refer
about an unusual presentation of local relapse in an old
patient submitted to a total gastrectomy in which surgical
approach permitted a good control of the disease.
Case report
Male, 71 years old; on July 27, 2004, he was submitted to
total gastrectomy with splenectomy and lymph-node dis-
section (D2) for an ulcerated adenocarcinoma of the
greater curvature of the upper third of the stomach.
Roux-en-Y stapled esofago-jejunoanastomosis was per-
formed and oral food intake resumed in 7th post-operative
day after X-ray control with hydro-soluble contrast. Hos-
pital stay was prolonged by left basal pneumonia
associated to pleural effusion; discharge occurred after one
month. Histological examination demonstrated an adeno-
carcinoma (Laurèn intestinal type, Ming infiltrating type)
extended to all layers of gastric wall and metastasis to
greater curvature lymph-nodes (station 4 of JGCA) [1]; the
others stations of JGCA (from 1 to 12, excluded 4) were
non metastatic (43 lymph-nodes were examined); it was
stage IIIA according to TNM classification (T3 N1 M0)
[2]. After discharge chemotherapy was given (Etoposide/
Leucovorin/5-fluorouracil, ELF-regimen) from September
2004 to March 2005. Follow-up was uneventful till
December 2005. In this period patient suffered of left
hypochondriac pain, mild dyspnoea and anorexia. Esopha-
gojejunoscopy was unremarkable. X-Ray confirmed left
basal pleural effusion; blood examination resulted only in
CEA increase (19.3 ug/L). CT scan demonstrated a bulk in
splenic area of about 8 cm in diameter and infiltrating
pancreatic tail with adhesions to left diaphragm, left colic
flexure and left kidney fascia (Fig. 1). On 7 February 2006,
he was submitted to explorative laparotomy that con-
firmed CT scan report. The bulk was resected en-bloc
with pancreatic tail, left colic flexure, a portion of left dia-
phragm and kidney fascia; bowel continuity was restored
by side-to-side stapled anastomosis; diaphragm was
directly sutured (Fig. 2). Accurate inspection of abdominal
cavity excluded others localizations of the disease. Post-
operative period was uneventful as regards surgical pro-
blems. Angina attack compared in 9th post-operative day;
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after resolution of this complication patient was dis-
charged. Histological examination resulted in poor differ-
entiated gastric carcinoma infiltrating colic wall and
pancreas with metastasis in one of nine peri-colic lymph-
nodes examinated.
Discussion
Loco-regional recurrence and distant metastases are
common events after surgery for gastric adenocarcinoma.
Abdominal extraluminal recurrence of gastric cancer is a
disarmimg condition because of poor therapeutic
chances. Generally it is a matter of peritoneal carcinosis
or multiple liver metastasis; in these cases surgery has lit-
tle opportunities to be useful. Literature reports rare
cases of single localization in abdominal cavity that may
be resected. Menzel [3] reported a case of infrarenal aor-
tic aneurysm whose detection permitted to discover
gastric carcinoma. A similar condition is reported by
Shimoyama [4] who diagnosed gastric cancer after
nephroureterectomy for hydronephrosis due to ureteral
metastasis. Imachi [5] referred about metastatic adeno-
carcinoma to the uterine cervix. Rare extrabdominal
localizations are reported: intramuscular gluteal tumour
[6], scalp and forehead [7], testis [8], axillary lymph node
[9]. Yoo and Colleagues [8] reported a multivariate analy-
sis of risk factors involved in the recurrence of gastric
cancer; in order they are lymph node metastasis, serosal
invasion, infiltrative or diffuse type, larger tumour size (4
cm or greater), undifferentiated tumour and proximally
located tumour. Serosal invasion and lymph node metas-
tasis were common risk factors for all recurrence pat-
terns. Buzzoni [10] underlined the role of radical surgery
respect more conservative surgery to reduce the rate of
loco-regional recurrence: particularly the pT stage was
related to loco-regional recurrence whereas pN stage had
importance on distant metastases. Motoori [11] devel-
oped a diagnostic system based on systematic analysis of
Figure 1 CT scan demonstrating a bulk in splenic area of about 8 cm in diameter and infiltrating pancreatic tail with adhesions to left
diaphragm, left colic flexure and left kidney fascia.
Figure 2 Surgical specimen comprehensive of the bulk resected
en-bloc with pancreatic tail, left colic flexure, a portion of left
diaphragm and kidney fascia.
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gene expression profiling to predict the recurrence at
clinically meaningful level: the prediction accuracy was
high especially in patients with small tumours in I and II
stage. Marrelli [12] obtained a scoring system with a
regression model based on follow-up data to define sub-
groups of patients at risk for recurrence after radical sur-
gery for gastric cancer. On the other hand, Bennet [13]
affirmed that follow-up did not identify no symptomatic
recurrence earlier than symptomatic one.
Our case is unusual in its presentation: an isolated bulk
involving neighbouring organs suitable for surgical resec-
tion. The result after the en-bloc resection is very amazing.
Considering the primary surgical specimen we may sup-
pose the modalities of the local relapse: the spleen and
local lymph-nodes were radically removed, but in spite of
that, local contamination during the first operation
remains the most reasonable interpretation. All risk factors
suggested by Yoo and Colleagues [8] were present in the
initial specimen: serosal invasion and nodal metastases,
large tumour size (7 x 5 cm on the specimen) infiltrative
and undifferentiated type and proximally located tumour.
We can speculate that chemotherapy has favoured the
delay of the clinical presentation of the recurrence.
Recently developed new agents such as irinotecan, taxanes
and capecitabine, provide more promising results also in
metastatic gastric cancer such as new molecular targeting
agents [14]. Encouraging perspectives may result from
IORT by virtue of its technical properties which permits
to exceed conventional doses [15]. We believe that an
appropriate association between varies therapeutic option
[16,17] (surgery, chemo and radiotherapy – EBRT and/or
IORT-) may bring about a change for a better manage-
ment of recurrent gastric cancer.
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